Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who owns the MMP?

...Take good note of each of the 12 items in the list to see how assets were moved out of TPL...

I do not read that the TPL ownership portion (if there is any) on the MMP (as an asset) was transfered.

Yes, to read the final version of Exhibit F (if there is one) would be fine.

May be BaNosser can provide it. The version posted on 8-31-2015 has NO Exhibit F, and there is one reference to an Exhibit F in the wording on page 53.

May be Ron can provide his interpretation on this.

Share
New Message
Please login to post a reply